Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders 90: Scale-Up Secrets: Cracking the Code of AAV Production with Ahmed Youssef - Part 2
Dive into the cutting-edge world of gene therapy as we unravel the complexities of AAV production. In this insightful episode, Ahmed Youssef, a seasoned AAV expert and Senior Process Development Manager at Ascend, explains how you can navigate the complex world of AAV scale-up and learn why thinking outside the box is crucial for success.
Key takeaways:
- Leverage early expert advice to ensure your therapeutic's long-term viability
- Explore innovative technologies like doggy bone DNA to reduce impurities
- Gain insights from industry pioneers to revolutionize your AAV production process
From plasmid alternatives to cutting-edge CDMO strategies, this episode is packed with game-changing information. Don't miss out on these invaluable scale-up secrets that could transform your gene therapy projects.
Tune in now and take your AAV production skills to the next level!
Connect with Ahmed Youssef:
LinkedIn: https://www.linkedin.com/in/ahmed-samir-youssef
Ascend: https://www.ascend-adv.com
Next Steps:
Wondering how to develop cell and gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at hello@bruehlmann-consulting.com
One bad CDMO decision can cost you two years and your Series A. If you're navigating tech transfer, CDMO selection, or IND prep, let's talk before it gets expensive. Two slots open this month.